Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,467 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 26-50 of 50 matching filings.

Per page
25
Current page
2
10-Q File 000-19034

QUARTERLY REPORT

Filing date
24 Oct 2012
Reporting date
30 Sep 2012
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
25 Jul 2012
Reporting date
30 Jun 2012
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
26 Apr 2012
Reporting date
31 Mar 2012
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
27 Oct 2011
Reporting date
30 Sep 2011
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
28 Jul 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
03 May 2011
Reporting date
31 Mar 2011
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
28 Oct 2010
Reporting date
30 Sep 2010
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
28 Jul 2010
Reporting date
30 Jun 2010
Next action
Verify source filing
10-Q File 000-19034

QUARTERLY REPORT

Filing date
29 Apr 2010
Reporting date
31 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .